Clinical Trials Logo

Filter by:
NCT ID: NCT04307160 Not yet recruiting - Clinical trials for Intermittent Exotropia

Relationship of Age at Surgery to Surgical Outcome After Surgery for Intermittent Exotropia

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

It is prospective cohort study to compare ( the surgical outcome) the motor and sensory outcome of early surgery (≤5 years of age) and late surgery ( ≥ 7 years of age) for intermittent exotropia.

NCT ID: NCT04309045 Not yet recruiting - Placebo Clinical Trials

Assessment of Cost-effectiveness in Two Empirically-based Psychotherapies for Borderline Personality Disorder: A Randomized Controlled Trial

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Patients suffering from borderline personality disorder (BPD) are considered frequent utilizers of psychiatric emergency rooms and of psychiatric hospitalizations. Nonetheless, recent studies challenge the effectiveness of psychiatric hospitalizations in reducing BPD symptoms, and some have even indicated potentially harmful effects such as increasing suicide risk post-discharge. These findings highlight the importance of effective outpatient treatments for BPD patients in public psychiatric hospital settings. In this study we aim to assess the effectiveness and cost-effectiveness of two empirically-based treatments for BPD: dialectical behavior therapy (DBT) and dynamic deconstructive psychotherapy (DDP).

NCT ID: NCT04309747 Not yet recruiting - Liver Cancer Clinical Trials

A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver Cancer

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, single-arm clinical trial. Four hospitals with national medical clinical trial institution qualifications are selected as clinical trial centers. Qualified participants will receive nanosecond pulse ablation therapy according to the routine procedures. The results will be recorded according to the requirements of the primary and secondary efficacy indicators. After then, statistical comparisons of effectiveness and safety of the product will be made according to groups.

NCT ID: NCT04311528 Not yet recruiting - Clinical trials for Human Papilloma Virus

9-valent HPV Vaccine in Postpartum Women

Start date: April 1, 2020
Phase: Phase 4
Study type: Interventional

This study will evaluate the immunogenicity of the 9-valent HPV vaccine in post-partum women age 16-45.

NCT ID: NCT04312555 Not yet recruiting - Clinical trials for Critical Limb Ischemia

Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia.

Start date: April 1, 2020
Phase: Phase 4
Study type: Interventional

The aim of this study is to assess the efficacy of Alprostadil (Prostaglandin E2) as adjuvant therapy after failure of direct but indirect angiosomal revascularization in patients with critical limb ischemia.

NCT ID: NCT04312646 Not yet recruiting - Thyroid Nodule Clinical Trials

Elastography in Thyroid Nodules

Start date: April 1, 2020
Phase:
Study type: Observational

Thyroid nodules are a common finding in the general population,however, they are mostly unpalpable and usually discovered either during neck ultrasound (US) examination or by pathological examination at autopsy. They are found in about 8% of adults. Most thyroid nodules ''incidentalomas" are benign, however 7% may be malignant. Early detection of thyroid cancer helps in early treatment and better survival US is an accurate method for detection of thyroid nodules; however, US has a low accuracy in differentiating between benign from malignant thyroid nodules . US could suggest a malignancy likelihood criteria of a thyroid nodule, such as hypoechogenicity, increased intranodular vascularity, irregular margins, microcalcifications, absent halo, and a taller-than-wide shape measured in the transverse dimension.

NCT ID: NCT04313803 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

CGM in Utah Valley

CGM
Start date: April 1, 2020
Phase:
Study type: Observational

The purpose of this study is to replicate the positive impact observed in IRB #1050955, but conduct this over a shorter period to potentially maximize patient outcomes and make care more affordable. Intermountain intends to build a diabetes program with CGM based on the findings. Senior stakeholders, clinicians and operators are aligned on this vision including the Community Based Care triad, Executive Leadership Team, and our Diabetes Prevention Program.

NCT ID: NCT04315519 Not yet recruiting - Type 2 Diabetes Clinical Trials

Effect of Blood Flow Restricted Aerobic Exercise in Type 2 Diabetes Mellitus

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Comparison of the effect of low intensity blood flow restricted aerobic exercise on glycemic and respiratory status with moderate aerobic exercise.

NCT ID: NCT04315675 Not yet recruiting - HIV/AIDS Clinical Trials

Improve Functional Health Status in Minority Women With HIV

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

HIV is no longer a death sentence, and with adherence to Rapid High Activity Antiretroviral (HAART) protocol women with HIV can achieve a normal life expectancy. In New Jersey there are 11,724 (32.9%) women living with HIV with Essex county in the lead, and they come they come from lowest social strata and educational level and are often single mothers. The purpose of this study is test three study interventions: a cognitive health promotion intervention, a guided imagery intervention and combination of both interventions. The Significance of the study is to improve the functional health and protocol adherence, to better enable women with HIV to achieve a normal life expectancy. The Methodology is an intervention study that uses a classic four group pretest post-test experimental design with random assignment, and the subjects for the study will be 80 women living with HIV. The interventions will be delivered within a three-week time frame followed by post testing at the end of the third week in Newark,New Jersey. The results of this study will be used as preliminary data to support a grant proposal to be submitted to the National Institutes of Health. The Results of this study are important as they will support improved health function and adherence to treatment protocols for marginalized poor women with HIV to achieve outcomes on par with men.

NCT ID: NCT04318756 Not yet recruiting - Pancreatic Cancer Clinical Trials

The Italian Version of Cancer Worry Scale

CWS_Ita
Start date: April 1, 2020
Phase:
Study type: Observational

An Italian language version of the Cancer Worry Scale is not available yet. The aim of this study is to develop and validate the Italian version of Cancer Worry Scale through subjects at high risk of pancreatic cancer for familiarity/genetic predisposition, or suffering from premalignant cystic lesions.